Vor Biopharma Inc. (VOR)
Last updated: 2026-10-20 23:28:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Vor Biopharma Inc. (VOR) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $18.98, with a market capitalization of $1.07B and a P/E ratio of 1.70. Over the past 52 weeks, its price has ranged from $6.50 to $30.40. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$1.07B | |
$18.06 | |
$1,272.40 | |
$2.62 | |
$18.04 | |
656.82K | |
960.74K | |
1.70 | |
$30.40 | |
$6.50 | |
-- | |
-- |
Vor Biopharma Inc. (VOR) After-Hours Stock Price
Vor Biopharma Inc. (VOR) is trading at $18.85 in after-hours trading as of 2026-10-20 23:00:00, up 4.49% ($0.81) from the regular-session close of $18.04.
After-hours trading shows how investors are pricing VOR after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Vor Biopharma Inc. (VOR) 7-Day Stock Price Change
Over the past seven days, Vor Biopharma Inc. (VOR) moved from $19.90 to $18.98, representing a decline of 4.62% ($0.92).
The stock traded between $17.73 and $20.52 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 857.60 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
VOR 52-Week Price Position
Position in Range: 52.2%
VOR is currently trading at $18.98, placing it 52.2% of the way from its 52-week low of $6.50 to its 52-week high of $30.40. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Vor Biopharma Inc. (VOR)?
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Vor Biopharma Inc. Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 76 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Vor Biopharma Inc. (VOR) Stock on MEXC
Eligible investors can buy real shares of Vor Biopharma Inc. (VOR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Vor Biopharma Inc. (VOR) stock price today?
2.Is VOR stock going up or down today?
3.What is VOR pre-market price?
4.What is VOR after-hours price?
5.Is VOR stock trading now?
6.Where does VOR sit relative to its 52-week high and low?
7.What sector is Vor Biopharma Inc. in?
8.What is Vor Biopharma Inc.'s market capitalization and where is it listed?
9.How is VOR valued in terms of P/E ratio and EPS?
10.Does Vor Biopharma Inc. pay a dividend?
Explore More US Stocks
Search Stocks
VOR Stock Calculator
Estimate the value between VOR shares and USD.
VOR Shares to USD
1.00 VOR shares = 18.981 USD
Calculations are estimates based on the latest available price and are for reference only.


